Analyst consensus rating
Lucid Diagnostics Analyst Rating: Strong Buy
LUCD is rated Strong Buy by 5 analysts with a $3.95 target. As of 2026-08-25.
Direct answer
Lucid Diagnostics's consensus rating is Strong Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $3.95.
Forecast evidence checked August 25, 2026.
Get free Lucid Diagnostics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.00
- Average price target
- $3.95
- High price target
- $9.25
- Low price target
- $2.00
- Low target gap
- +100%
- Target upside
- +295%
- High target gap
- +825%
- Target range width
- 725%
- Consensus rating
- Strong Buy
- Analysts
- 5
- Evidence date
- August 25, 2026
- Valid through
- September 1, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Lucid Diagnostics?
Lucid Diagnostics has a verified Strong Buy consensus. The same dataset has an average price target of $3.95.
How far are Lucid Diagnostics's low and high targets from the recorded price?
The low target implies +100%, while the high target implies +825%.
How many analysts are included in Lucid Diagnostics's consensus?
The verified consensus includes 5 analysts.
How is Lucid Diagnostics's target upside or downside calculated?
The average target of $3.95 is divided by the recorded price of $1.00, then one is subtracted to produce +295%. This does not guarantee a future return.
When was Lucid Diagnostics's analyst forecast verified?
The data was verified on 2026-08-25. The dataset is valid through 2026-09-01.